Trial Profile
A Study to Examine the Tolerability, Safety and Pharmacokinetics of Single Oral Doses of RGH-618 in Healthy Male Volunteers
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 31 May 2016
Price :
$35
*
At a glance
- Drugs RGH 618 (Primary)
- Indications Anxiety; Anxiety disorders
- Focus Adverse reactions; First in man
- Sponsors Gedeon Richter
- 20 Apr 2016 New trial record